Insider · CIK 0001785894

Jones Aranthan II

Reports to the SEC for 1 company · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001785894

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-09-15	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	+4,277 sh	$12.27	+$52.5K	90,962
2021-09-15	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	+7,842 sh	$11.32	+$88.8K	98,804
2021-09-15	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−16.8K sh	$16.49	−$277K	81,980
2021-09-15	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	−4,277 sh	—	—	33,224
2021-09-15	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	−7,842 sh	—	—	47,158
2021-07-26	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−7,250 sh	$19.69	−$143K	86,685
2021-03-15	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	+15K sh	$11.32	+$170K	111,935
2021-03-15	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−18K sh	$17.72	−$319K	93,935
2021-03-15	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	−15K sh	—	—	55,000
2021-03-02	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−3,865 sh	$18.04	−$69.7K	96,935
2021-02-24	VNDAVanda Pharmaceuticals Inc.A Award	Chief Corp. Affairs Officer	AAward	+25.8K sh	—	—	101,287
2021-02-24	VNDAVanda Pharmaceuticals Inc.M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	+22.5K sh	$12.27	+$276K	123,786
2021-02-24	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−23K sh	$20.01	−$460K	100,800
2021-02-24	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	Chief Corp. Affairs Officer	AAward	+61.2K sh	—	—	61,200
2021-02-24	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Corp. Affairs Officer	MExercise/Conversion	−22.5K sh	—	—	37,501
2020-08-12	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−7,200 sh	$11.81	−$85K	75,487
2020-07-27	VNDAVanda Pharmaceuticals Inc.S Sale	Chief Corp. Affairs Officer	SSale	−7,313 sh	$10.62	−$77.6K	82,687
2020-02-26	VNDAVanda Pharmaceuticals Inc.A Award	Chief Corp. Affairs Officer	AAward	+30K sh	—	—	90,000
2020-02-26	VNDAVanda Pharmaceuticals Inc. · Employee Stock Option (Right to Buy)A Award	Chief Corp. Affairs Officer	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
Sep 174
Jones Aranthan II0001209191-21-056530
SEC(opens sec.gov)
Jul 274
Jones Aranthan II0001209191-21-048276
SEC(opens sec.gov)
Mar 164
Jones Aranthan II0001209191-21-020782
SEC(opens sec.gov)
Mar 34
Jones Aranthan II0001209191-21-017273
SEC(opens sec.gov)
Feb 264
Jones Aranthan II0001209191-21-014873
SEC(opens sec.gov)
Aug 144
Jones Aranthan II0001209191-20-046804
SEC(opens sec.gov)
Jul 294
Jones Aranthan II0001209191-20-043998
SEC(opens sec.gov)
Feb 284
Jones Aranthan II0001209191-20-014126
SEC(opens sec.gov)

Companies

Vanda Pharmaceuticals Inc.Chief Corp. Affairs OfficerVNDA

Address

C/O VANDA PHARMACEUTICALS INC. 2200 PENNSYLVANIA AVENUE, SUITE 300E

WASHINGTON, DC, 20037